EMA outlines manufacturing quality docs for biologics trials
The EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials.
The EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials.
The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.